Tokyo, Japan

Tomoko Terauchi

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Innovations in Antibody-Drug Conjugates: The Work of Tomoko Terauchi

Introduction

Tomoko Terauchi, an accomplished inventor based in Tokyo, Japan, is at the forefront of innovation in the field of biopharmaceuticals. With a remarkable portfolio of six patents, her research primarily focuses on antibody-drug conjugates that promise to revolutionize cancer treatment and diabetes management.

Latest Patents

Among her latest contributions are significant patents pertaining to antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines. This novel invention includes an antibody-pyrrolodiazepine derivative and its conjugates, providing methods for their clinical use. Additionally, Terauchi’s research discloses compounds classified as alkyl benzene sulfonyl ureas, which are potentially effective as oral anti-diabetics. Another notable patent includes an anti-CD37 antibody-drug conjugate that targets CD37-positive tumor cells, particularly malignant B-cell lymphoma. Her work elucidates the development of a humanized anti-CD37 antibody with internalization capabilities, opening avenues for effective tumor therapy.

Career Highlights

Tomoko Terauchi has developed a distinguished career at Daiichi Sankyo Company, Limited, where she contributes to cutting-edge innovations in drug development. Her extensive work on antibody-drug conjugates has established her as a key player in advancing therapeutic options for complex diseases like cancer and diabetes.

Collaborations

Throughout her career, Terauchi has had the opportunity to collaborate with esteemed colleagues, including Kensuke Nakamura and Narihiro Toda. These collaborations reflect a synergy of expertise that enhances the innovation process within the organization, spearheading remarkable advancements in the pharmaceutical industry.

Conclusion

Tomoko Terauchi's inventive contributions, particularly in the realm of antibody-drug conjugates, exemplify the power of scientific innovation in healthcare. Her patents not only highlight her exceptional talent as an inventor but also underscore her commitment to advancing medical therapies for critical health conditions. As she continues her work at Daiichi Sankyo Company, Limited, her future contributions hold great potential for further innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…